Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Curzio Ruegg
Inhibition of Host NOX1 Blocks Tumor Growth and Enhances Checkpoint Inhibitor–based Immunotherapy
Life Science Alliance
Plant Science
Ecology
Genetics
Molecular Biology
Biochemistry
Mutagenesis
Health
Toxicology
Related publications
A CDK9 Inhibitor May Suppress Tumor Growth and Enhance Immunotherapy
Cancer Discovery
Oncology
Macrophage Checkpoint Blockade and Tumor Mechanics in a Cell-Based Immunotherapy
Biophysical Journal
Biophysics
Inhibition of Gastric Tumor Growth by a Novel Hsp90 Inhibitor
Biochemical Pharmacology
Biochemistry
Pharmacology
Neurologic Autoimmunity in the Era of Checkpoint Inhibitor Cancer Immunotherapy
Mayo Clinic Proceedings
Medicine
Local Angiotensin II Contributes to Tumor Resistance to Checkpoint Immunotherapy
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
A Tumor-Peptide Based Nanoparticle Vaccine Elicits Efficient Tumor Growth Control in Anti-Tumor Immunotherapy
Molecular Cancer Therapeutics
Cancer Research
Oncology
The CDK4/6 Inhibitor Abemaciclib Induces a T Cell Inflamed Tumor Microenvironment and Enhances the Efficacy of PD-L1 Checkpoint Blockade
Cell Reports
Biochemistry
Genetics
Molecular Biology
Nonmuscle Invasive Urothelial Cancer— Bacillus Calmette–Guérin Instillation or Checkpoint Inhibitor Immunotherapy?
Memo - Magazine of European Medical Oncology
Oncology
Hematology
Carbonic Anhydrase IX Promotes Tumor Growth and Necrosis in Vivo and Inhibition Enhances Anti-Vegf Therapy
Clinical Cancer Research
Cancer Research
Oncology